Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3708804013 | Product containing bevacizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3708805014 | Bevacizumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing bevacizumab in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing bevacizumab in parenteral dose form (medicinal product form) | est un(e) (attribut) | Product containing bevacizumab (medicinal product) | true | Inferred relationship | Some | ||
| Product containing bevacizumab in parenteral dose form (medicinal product form) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Product containing bevacizumab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | bevacizumab | true | Inferred relationship | Some | 1 | |
| Product containing bevacizumab in parenteral dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR